<DOC>
	<DOCNO>NCT00723346</DOCNO>
	<brief_summary>Primary objective : - To explore relation 3 dos GRASPA duration asparagine depletion ( &lt; 2Âµmol/l ) Secondary objective : - Pharmacokinetic / Pharmacodynamic parameter - toxicity - Study duration : 2 year - Study treatment : Red blood cell load L asparaginase versus native L asparaginase - Associated treatment : COPRALL chemotherapy - Randomization : centralise randomisation scratch list</brief_summary>
	<brief_title>Administration Allogenic Red Blood Cells Loaded L-asparaginase Cases Relapse Acute Lymphoblastic Leukaemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Subject 1 55 year old Subject acute lymphoblastic leukaemia lymphoblastic lymphoma ( exclude burkitt lymphoma ) relapse first remission ( medullary SNC relapse ) Or patient still refractory first line chemotherapy ALL Patient give write informed consent ( 2 parent child )</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Relapse</keyword>
	<keyword>Lymphoma lymphoblastic</keyword>
</DOC>